Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT00693953

Using the Digital EEG Spectral Analysis in Assessing Neuroelectrical Processing Abnormalities in Autism

Status
Withdrawn
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Yellen & Associates, Inc. · Academic / Other
Sex
All
Age
5 Years – 25 Years
Healthy volunteers
Not accepted

Summary

Individuals with Autism Spectrum Disorder will have abnormal DESA® results. Our objective is to use neuroelectrical measures to determine the degree of processing abnormalities in individuals with Autism. The study will survey processing patterns and will locate and evaluate the degree(s) of abnormalities for further study. The abnormal results of comprehensive neuroelectrical evaluations of individuals with Autism when compared to the normative database will provide objective, verifiable, neurophysiological information with which to form novel approaches to the disorder.

Detailed description

The research method will be: gathering, analyzing and utilizing data. We will observe research subjects through neuroelectrical instrumentation, then, compare results to retrospective information collected from research subjects and a normative database. A qualified neurologist thoroughly familiar with electrophysiology will interpret the data, and analyze it to explore the abnormalities. The hypothesis will be evaluated. We will, then, utilize the results to find data-based forms of treatment for those with the disorder.

Conditions

Timeline

Start date
2010-01-01
Primary completion
2011-01-01
Completion
2012-12-01
First posted
2008-06-09
Last updated
2009-10-02

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00693953. Inclusion in this directory is not an endorsement.